Management of Benign Follicular Nodules with Cystic Degeneration

Risk Assessment and Classification

Benign follicular nodules with cystic degeneration classified as Bethesda category B (benign) have a risk of malignancy <1% when they show typical benign sonographic features, as per the American College of Radiology 1, 2

Observation is appropriate for asymptomatic nodules with maximal diameter <2 cm, as recommended by the American College of Radiology 3
No routine follow-up is necessary if the nodule is stable and asymptomatic, according to the American College of Radiology 1, 2
Consider repeat ultrasound in 1 year to confirm stability, as suggested by the American College of Radiology 2

Follow-up ultrasound in 8-12 weeks for postmenopausal women and in 1 year for premenopausal women, as recommended by the American College of Radiology 2
Consider repeat fine-needle aspiration (FNA) if there are changes in size or sonographic features, according to the European Society for Medical Oncology 4

Consider referral to a specialist for further evaluation, as recommended by the American College of Radiology 2

Thermal ablation is indicated for benign nodules that cause clinical symptoms, create cosmetic concerns, or have maximal diameter ≥2 cm, as recommended by the American College of Radiology 3
Surgical management should be considered for nodules with compressive symptoms not responsive to less invasive approaches, according to the European Society for Medical Oncology 4

Ultrasound evaluation at regular intervals (6-12 months initially, then annually if stable), as recommended by the American College of Radiology 2
Repeat FNA should be considered if there is significant growth (>20% increase in at least two dimensions), according to the European Society for Medical Oncology 4

Overtreatment of asymptomatic, stable benign nodules - most require only observation, as recommended by the American College of Radiology 2, 3

Larger nodules may require more aggressive management due to potential for compressive symptoms, according to the National Comprehensive Cancer Network 5
Physical examination with or without ultrasound every 6 to 12 months for 1 to 2 years to assess stability, as recommended by the National Comprehensive Cancer Network 5
If the lesion increases in size, repeat tissue sampling should be considered, as suggested by the National Comprehensive Cancer Network 5
If the lesion remains stable, return to routine screening, according to the National Comprehensive Cancer Network 5

Therapeutic aspiration can be performed for simple cysts with persistent clinical symptoms, as indicated by the National Comprehensive Cancer Network 6
For complicated cysts that increase in size on follow-up, a tissue biopsy should be performed, as recommended by the National Comprehensive Cancer Network 6
For cystic nodules classified as complicated, options include aspiration or short-term follow-up with physical examination and ultrasound, according to the National Comprehensive Cancer Network 6
If blood-free fluid is obtained on aspiration and the mass resolves, the patient should be monitored for any change, as suggested by the National Comprehensive Cancer Network 6
If the mass recurs after aspiration, ultrasound with image-guided biopsy or surgical excision is warranted, as recommended by the National Comprehensive Cancer Network 6